RxDoctor Payments Data

John Oliver, MD

Gynecology · Wasilla, AKNPI 1093778029

Payments from drug & device makers

$4,348in general payments, 2019–2025

Across 41 payments — averaging $106.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$3K
  • Astellas Pharma US Inc$334
  • Sumitomo Pharma America, Inc.$149
  • Hologic Sales And Service, LLC$103
  • AbbVie$65
  • Myovant Sciences Inc.$59
  • plus $166 from 4 others

What the payments were for

  • Travel & lodging$1,89444%
  • Food & beverage$67115%
  • Education$1,78241%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few gynecology providers in Alaskato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$101,125
Medicare patients
200
Services billed
834

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron39$49,620
Estradiol310$12,331
LinzessLinaclotide11$9,657
EstringEstradiol11$5,866
Depo-EstradiolEstradiol Cypionate19$3,769
Lubiprostone11$2,213
Methenamine Hippurate14$1,199
Terconazole26$757
Oxybutynin Chloride ErOxybutynin Chloride25$717
Norethindrone Acetate21$662
Solifenacin Succinate18$459
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip15$308
Naproxen Sodium14$250
Fluconazole20$221
Cephalexin21$70

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$334$49,62039 claims
AbbVieLinzess$65$9,65711 claims
PfizerEstring$51$5,86611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few gynecology providers in Alaskaon file to place this against a meaningful peer group, so we don't.

Other gynecology in Wasilla

Where these figures come from

Is this you, or does something look wrong? →